Article

The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy

Diabetes, Metabolic Syndrome and Obesity · 2020 · Zhao C, Yin X, Zhao C

Key facts

Title The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy
First author Zhao C, Yin X, Zhao C
Journal Diabetes, Metabolic Syndrome and Obesity
Published Jan 8, 2020
DOI 10.2147/DMSO.S231851
Devices mentioned 050718, 071715, 214200, K021943, K043197, K053529, K061118, K072543, K073231, K081318, K082513, K120558 and 3 more
Product codes mentioned CBK, CGA, DBM, MRZ, NBW, MSX

At a glance

  • 10–99 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature